Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)Matthias Preusser, Wolfgang Wick, Antonio Silvani et al.|Neuro-Oncology|2021Cited by 81
Management evaluation of metastasis in the brain (MEMBRAIN)—a United Kingdom and Ireland prospective, multicenter observational studyJosephine Jung, John W. Norris, Karol P. Budohoski et al.|Neuro-Oncology Practice|2019Cited by 5
Management Evaluation of Metastasis in the Brain (MEMBRAIN) – A UK & Ireland prospective, multicentre observational studyJosephine Jung, Francesco Vergani, Jignesh Tailor et al.|Neuro-Oncology|2019Cited by 1
Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.Juanita Lopez, Joachim P. Steinbach, Simon Haefliger et al.|Journal of Clinical Oncology|2023Cited by 1